No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysis

OBJECTIVES: To compare the risk of serious adverse events, serious infections and death caused by methotrexate and biological disease-modifying antirheumatic drug (bDMARD) combination therapy versus a bDMARD prescribed as monotherapy in rheumatoid arthritis (RA). METHODS: A systematic literature rev...

Full description

Saved in:
Bibliographic Details
Published in:RMD Open
Main Authors: Baradat, Claire, Degboé, Yannick, Constantin, Arnaud, Cantagrel, Alain, Ruyssen-Witrand, Adeline
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2017
Subjects:
Rheumatoid Arthritis
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337718/
https://ncbi.nlm.nih.gov/pubmed/28270933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2016-000352
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items